Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension

ObjectiveTo investigate the clinical efficacy and therapeutic value of partial splenic artery embolization (PSE) for treating portal hypertension in patients with liver cirrhosis. MethodsTwenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were trea...

Full description

Bibliographic Details
Main Author: DUAN Liwei
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2013-02-01
Series:Linchuang Gandanbing Zazhi
Subjects:
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=5250&ClassID=11515591
id doaj-94b187306a284a91ac2ead97fbd4e243
record_format Article
spelling doaj-94b187306a284a91ac2ead97fbd4e2432020-11-24T22:15:10ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52562013-02-01292142145Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertensionDUAN LiweiObjectiveTo investigate the clinical efficacy and therapeutic value of partial splenic artery embolization (PSE) for treating portal hypertension in patients with liver cirrhosis. MethodsTwenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were treated with PSE. Diameter and blood flow velocity of the portal vein (PV) and splenic vein (SV) were measured by color Doppler ultrasound before PSE (baseline) and after PSE (postoperative week 1 and months 1, 3, and 6). Statistical significance of differences was assessed by paired t-test. ResultsBoth the PV and SV blood flow velocities were significantly enhanced after PSE (all postoperative times vs. baseline, P<0.05). SV diameter was significantly reduced after PSE (all postoperative times vs. baseline, P<005). PV diameter, however, was not significantly reduced at six months after PSE (vs. baseline, P≥0.05). ConclusionPSE can reduce portal vein pressure in patients with liver cirrhosis.http://www.lcgdbzz.org/qk_content.asp?id=5250&ClassID=11515591splenic arteryembolismliver cirrhosishypertensionportal
collection DOAJ
language zho
format Article
sources DOAJ
author DUAN Liwei
spellingShingle DUAN Liwei
Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
Linchuang Gandanbing Zazhi
splenic artery
embolism
liver cirrhosis
hypertension
portal
author_facet DUAN Liwei
author_sort DUAN Liwei
title Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
title_short Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
title_full Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
title_fullStr Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
title_full_unstemmed Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
title_sort hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
publishDate 2013-02-01
description ObjectiveTo investigate the clinical efficacy and therapeutic value of partial splenic artery embolization (PSE) for treating portal hypertension in patients with liver cirrhosis. MethodsTwenty-three patients diagnosed with liver cirrhosis of different etiology and with portal hypertension were treated with PSE. Diameter and blood flow velocity of the portal vein (PV) and splenic vein (SV) were measured by color Doppler ultrasound before PSE (baseline) and after PSE (postoperative week 1 and months 1, 3, and 6). Statistical significance of differences was assessed by paired t-test. ResultsBoth the PV and SV blood flow velocities were significantly enhanced after PSE (all postoperative times vs. baseline, P<0.05). SV diameter was significantly reduced after PSE (all postoperative times vs. baseline, P<005). PV diameter, however, was not significantly reduced at six months after PSE (vs. baseline, P≥0.05). ConclusionPSE can reduce portal vein pressure in patients with liver cirrhosis.
topic splenic artery
embolism
liver cirrhosis
hypertension
portal
url http://www.lcgdbzz.org/qk_content.asp?id=5250&ClassID=11515591
work_keys_str_mv AT duanliwei hemodynamiceffectsofpartialsplenicarteryembolizationinpatientswithlivercirrhosisandportalhypertension
_version_ 1725795685985419264